Indoco Remedies

Price chart

Previous close

₹218.85

Open

₹221.00

Day high

₹223.66

Day low

₹216.90

Listed on NSE since 14 January 2005.

Market value

₹2,017.55 Cr

P/E (trailing)

63.62

EPS (trailing)

₹3.44

Price to book

1.87

Dividend yield

0.09%

Return on equity

3.2%

Debt to equity

1.04

Profit margin

1.7%

Beta

0.66

Volume today

74,369

Average volume

10.52 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Indoco Remedies’s results filed with NSE, consolidated (the whole group). Net profit is the share of Indoco Remedies’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Indoco Remedies’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, extractables and leachables studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

6,000

Company website · Profile: Yahoo Finance

No headlines name Indoco Remedies in the last day or two.

• Dividend - Re 0.20 Per Share

  Dividend · ex-date 10 September 2026

• Dividend - Re 0.20 Per Share

  Dividend · ex-date 4 September 2025

• Annual General Meeting/Dividend - Rs 1.50 Per Share

  Dividend · ex-date 19 September 2024

• Annual General Meeting/Dividend - Rs 2.25 Per Share

  Dividend · ex-date 18 September 2023

• Annual General Meeting/Dividend - Rs 1.50 Per Share/Special Dividend- Rs 0.75 Per Share

  Dividend · ex-date 14 September 2022

• Annual General Meeting/Dividend - Rs 1.50 Per Share

  Dividend · ex-date 17 September 2021

• Annual General Meeting/Dividend - Re 0.30 Per Sh

  Dividend · ex-date 18 September 2020

• Annual General Meeting/Dividend - Rs 0.30 Per Share

  Dividend · ex-date 22 August 2019

Source: NSE. Latest first, 8 of 20.